CONSERVATION OF SEEDS OF Myrcianthes pungens (Berg) Legr. IN DIFFERENT PACKAGING IN A CONTROLLED ENVIRONMENT1 by Patrícia Gibbert (6854006)

“…During storage, the water content of the seeds in the plastic and glass containers varied little, but decreased in the paper packaging. The germination was maintained for ten months when the seeds were stored in plastic containers and for two months in the glass and paper ones. …”

Set-point viral load and the basic reproductive number, , as a function of CTL-mediated killing. by Christian L. Althaus (112118)

“…<p>The left panels depict the behavior when killing is induced with a total rate per day. The viral load decreases sharply for d (A) since falls below one, and the infection is cleared (C). …”

Video2_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.MP4 by Kai Wang (21246)

“…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD₉₀ prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”

Video2_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.MP4 by Kai Wang (21246)

“…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD₉₀ prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”

A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK by Juan Francisco Hernandez (135605)

“…A small decrease of −0.6 DDDs/month (−1.2; −0.05) was observed in Dutch SSRI use shortly after 2003–2004. …”

Image8_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Table1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.XLSX by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Image4_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Image3_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Video1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.mov by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Image1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

DataSheet1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.docx by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Image7_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

Image6_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…During in vitro experiments, we have shown that treatment with mitomycin C does not lead to a decrease in cell viability. …”

The kava root extract and kavalactones down-regulate expression of AR and AR target genes (<i>PSA</i> and <i>TMPRSS2</i>) via accelerating the degradation of AR protein. by Xuesen Li (48046)

“…(<b>D</b>). C4-2B cells were pretreated with 10 µg/ml cycloheximide for 2 hours and then supplemented with kava root extract or 5′6;-dehydrokawain at a concentration of their IC_{50 s} for different periods of time. …”

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

“…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”

Image_2_3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo.TIF by Xiaorong Fu (106929)

“…Additionally, we observed that 3-DSC decreased SK-MEL-2 cell-derived xenograft tumor growth through attenuating phosphorylation of TOPK and its downstream effectors including ERK, RSK, and c-Jun.…”

The combination of discontinuous dexamethasone and PEGylated asparaginase shows synergistic efficacy in bone marrow. by Seth E. Karol (780961)

Supplementary Figures from A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis by Bo Kyung A. Seong (14926620)

“…Supplementary Figure 4 - CADM1 over-expression decreases migration of SHEP cell line. Supplementary Figure 5 - Verteporfin (VP), a pharmacological inhibitor of YAP, induces apoptosis and decreases migration of metastatic cells in in vitro and inhibits the metastatic phenotype in vivo. …”